(Q71611886)

English

A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer

scientific article published on 01 July 1996

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8839900

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8839900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

title

A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8839900

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8839900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

main subject

metastatic breast cancer

1 reference

1 reference

C I Falkson

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8839900

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8839900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

H C Falkson

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8839900

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8839900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

publication date

1 July 1996

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8839900

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8839900%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

Europe PubMed Central

PubMed publication ID

8839900

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8839900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

volume

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8839900

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8839900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8839900

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8839900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

page(s)

465-469

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8839900

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8839900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

Identifiers

DOI

10.1093/OXFORDJOURNALS.ANNONC.A010634

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8839900

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8839900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 October 2019

PubMed publication ID

8839900

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8839900

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8839900%20AND%20SRC:MED&resulttype=core&format=json

(Q71611886)

A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)